Literature DB >> 12817190

Evidence for renal vascular remodeling in angiotensin II-induced hypertension.

Amanda J Edgley1, Michelle M Kett, Warwick P Anderson.   

Abstract

OBJECTIVES: To determine whether 'slow pressor' hypertension from systemic angiotensin (Ang II) infusion was associated with renal vascular structural remodeling of the renal resistance vessels and glomerulus.
METHODS: Ang II (4.5-10 ng/kg per min) or vehicle was infused for 10 days. Renal resistance vascular lumen changes were assessed at 10 days as changes in renal pressure flow and pressure-glomerular filtration rate (GFR) and pressure-Na+ excretion in maximally dilated, isotonically perfused kidneys.
RESULTS: Low-dose, initially subpressor Ang II infusion for 10 days increased conscious arterial pressure by 27 mmHg compared to vehicle-infused rats (140 +/- 7 and 113 +/- 2 mmHg, respectively). There was no change in the pressure-flow relationship but the slope of the pressure-GFR relationship was reduced in the rats treated with Ang II. These changes are consistent with equal and opposite pre-and post-glomerular effects (i.e., increased pre-glomerular vessel resistance and reduced post-glomerular vessel resistance) and reduced glomerular ultrafiltration coefficient. There was also a significant reduction in pressure-dependent Na+ excretion.
CONCLUSIONS: Slow pressor Ang II-induced hypertension was associated with apparent pro-hypertensive changes in the kidney involving pre/post-glomerular vessel remodeling as indicated by an apparent reduction in pre-glomerular lumen dimensions, a reduced glomerular filtration capacity and a reduction in the pressure natriuresis relationship.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12817190     DOI: 10.1097/00004872-200307000-00031

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

2.  NMDA Receptor Plasticity in the Hypothalamic Paraventricular Nucleus Contributes to the Elevated Blood Pressure Produced by Angiotensin II.

Authors:  Michael J Glass; Gang Wang; Christal G Coleman; June Chan; Evgeny Ogorodnik; Tracey A Van Kempen; Teresa A Milner; Scott D Butler; Colin N Young; Robin L Davisson; Costantino Iadecola; Virginia M Pickel
Journal:  J Neurosci       Date:  2015-07-01       Impact factor: 6.167

3.  Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension.

Authors:  Yu-Ming Kang; Ying Ma; Jin-Ping Zheng; Carrie Elks; Srinivas Sriramula; Zhi-Ming Yang; Joseph Francis
Journal:  Cardiovasc Res       Date:  2009-02-25       Impact factor: 10.787

4.  Inhibition of extracellular signal-regulated kinases ameliorates hypertension-induced renal vascular remodeling in rat models.

Authors:  Li Jing; Jianzhong Zhang; Jinping Sun; Fengying Guo; Xin An; Kan Yang; Ping Andy Li
Journal:  Int J Mol Sci       Date:  2011-11-28       Impact factor: 5.923

Review 5.  Kidney dysfunction in patients with pulmonary arterial hypertension.

Authors:  N P Nickel; J M O'Leary; E L Brittain; J P Fessel; R T Zamanian; J D West; E D Austin
Journal:  Pulm Circ       Date:  2017-03-13       Impact factor: 3.017

6.  Long-Term Angiotensin II Infusion Induces Oxidative and Endoplasmic Reticulum Stress and Modulates Na+ Transporters Through the Nephron.

Authors:  Bruna Bezerra Lins; Fernando Augusto Malavazzi Casare; Flávia Ferreira Fontenele; Guilherme Lopes Gonçalves; Maria Oliveira-Souza
Journal:  Front Physiol       Date:  2021-04-01       Impact factor: 4.566

Review 7.  Diet-Induced Hyperinsulinemia as a Key Factor in the Etiology of Both Benign Prostatic Hyperplasia and Essential Hypertension?

Authors:  Wolfgang Kopp
Journal:  Nutr Metab Insights       Date:  2018-05-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.